Summary & Overview
CPT 20975: Surgical Implantation of Electrical Bone Growth Stimulator
CPT code 20975 identifies the surgical implantation of an electrical bone growth stimulation device placed at a fracture site to promote bone healing. The procedure represents an important adjunctive option in orthopedic care for fractures at risk of delayed union or nonunion and has implications for hospital and ambulatory surgery workflows, device utilization, and coverage policy nationally. Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the code, typical sites of service, and how major payers approach coverage for implanted electrical bone stimulators. The publication summarizes benchmark utilization metrics, common billing and coding considerations, and recent policy developments affecting coverage and reimbursement for surgically implanted bone stimulation devices. It also provides clinical context regarding indications for use and where the service fits among other fracture-healing interventions. Data not available in the input is noted where applicable, and the analysis is presented for a national audience without state-specific variation.
Billing Code Overview
CPT code 20975 describes the surgical implantation of a device that emits electrical impulses at the site of a broken bone to promote bone healing. This procedure is a surgical bone stimulation implant intended to enhance fracture repair when adjunctive electrical stimulation is clinically indicated.
-
Service type: Surgical implantation of an electrical bone growth stimulation device.
-
Typical site of service: Hospital operating room or ambulatory surgery center, depending on clinical setting and patient factors.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with a closed, nonunion midshaft tibial fracture sustained 6 months prior presents with persistent pain and radiographic evidence of delayed union. Conservative measures including immobilization and orthobiologic adjuncts have failed. The orthopedic surgeon schedules surgical implantation of a transosseous or percutaneous bone growth stimulator device that delivers electrical impulses at the fracture site to promote osteogenesis. The typical clinical workflow includes preoperative evaluation and informed consent, perioperative antibiotic prophylaxis, intraoperative implantation of the stimulator (epicortical electrode or intramedullary pulse generator depending on device), device programming and testing, wound closure, and postoperative follow-up to assess device function and radiographic progression of healing. Device interrogation and outpatient physical therapy are commonly performed during recovery. Typical site of service is an ambulatory surgery center or hospital outpatient department; inpatient admission may occur if comorbidities or concomitant procedures require it.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for the procedure (document increased complexity). |
23 |